Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTALYSE PE: Acoustic Pulse Thrombolysis in Pulmonary Embolism
NCT02396758Phase 4Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Jun 2015
- Primary completion
- Apr 2019
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial in pulmonary embolism (PE) (4 arms), sponsored by Boston Scientific Corporation. Primary endpoints: Change From Baseline in the Right Ventricle (RV) Diameter-to-Left Ventricle (LV) Diameter Ratio at 48 hours and Number of Participants With Major Bleeding at 72 hours. Started Jun 2015; status: completed.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02396758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396758.